Betts M, Flight PA, L Paramore C, Tian L, Milenković D, Sheth S.  2020.  Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.. Clin Ther. 42(2):322-337.e2.

Sheth S.  2019.  Strategies for managing transfusional iron overload: conventional treatments and novel strategies.. Curr Opin Hematol. 26(3):139-144.

Sheth S.  2019.  Stem cell transplantation in sickle-cell disease.. Lancet Haematol. 6(11):e547-e548.

Grace RF, Rose C, D Layton M, Galactéros F, Barcellini W, D Morton H, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM et al..  2019.  Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.. N Engl J Med. 381(10):933-944.

Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..  2022.  The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.

Goss C, Giardina P, Degtyaryova D, Kleinert D, Sheth S, Cushing M.  2014.  Red Blood Cell Transfusions for Thalassemia: Results of a Survey Assessing Current Practice and Proposal of Evidence-Based Guidelines. Transfusion. 54(7):1773-81.

L'Acqua C, Bandyopadhyay S, Francis RO, McMahon DJ, Nellis M, Sheth S, Kernie SG, Brittenham GM, Spitalnik SL, Hod EA.  2015.  Red Blood Cell Transfusion is Associated with Increased Hemolysis and an Acute Phase Response in a Subset of Critically Ill Children. Am J Hematol. 90(10):915-20.

Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, Guo Y, Deh K, Liu Z, Margolis D et al..  2019.  Rapid automated liver quantitative susceptibility mapping.. J Magn Reson Imaging. 50(3):725-732.

Chonat S, Eber SW, Holzhauer S, Kollmar N, D Morton H, Glader B, Neufeld EJ, Yaish HM, Rothman JA, Sharma M et al..  2021.  Pyruvate kinase deficiency in children.. Pediatr Blood Cancer. 68(9):e29148.

Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H et al..  2017.  Prolonged Red Cell Storage Before Transfusion Increases Extravascular Hemolysis. J Clin Invest. 127(1):375-382.

van Beers EJ, van Straaten S, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA et al..  2019.  Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.. Haematologica. 104(2):e51-e53.

Chien KA, Hammad HT, Gerber L, Sheth S, Sockolow R, Kucine N.  2018.  Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.. J Pediatr Gastroenterol Nutr. 66(2):286-288.

Mensah C, Sheth S.  2021.  Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.. Hematology Am Soc Hematol Educ Program. 2021(1):607-613.

Tang H, Jensen JH, Sammet CL, Sheth S, Swaminathan SV, Hultman K, Kim D, Wu EX, Brown TR, Brittenham GM.  2014.  MR Characterization of Hepatic Storage Iron in Transfusional Iron Overload. J Magn Reson Imaging. 39(2):307-16.

Sheth S, Allen CJ, Farrell DE, Tripp JH, Jafari R, Wang Y, Brittenham GM.  2019.  Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry.. Clin Imaging. 55:65-70.

Sammet CL, Swaminathan SV, Tang H, Sheth S, Jensen JH, Nunez A, Hultman K, Kim D, Wu EX, Brittenham GM et al..  2013.  Measurement and Correction of Stimulated Echo Contamination in T2-Based Iron Quantification. Magn Reson Imaging. 31(5):664-8.

Sheth S.  2014.  Iron Chelation: An Update. Curr Opin Hematol. 21(3):179-85.

Al-Samkari H, van Beers EJ, D Morton H, Eber SW, Chonat S, Kuo KHM, Kollmar N, Wang H, Breakey VR, Sheth S et al..  2022.  Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.. Blood Adv. 6(6):1844-1853.

Hoshino A, Kim HSang, Bojmar L, Gyan KEnnu, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S et al..  2020.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.. Cell. 182(4):1044-1061.e18.

Frangoul H, Altshuler D, M Cappellini D, Chen Y-S, Domm J, Eustace BK, Foell J, de la Fuente J, Grupp S, Handgretinger R et al..  2021.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.. N Engl J Med. 384(3):252-260.

Boscoe AN, Yan Y, Hedgeman E, van Beers EJ, Al-Samkari H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S et al..  2021.  Comorbidities and complications in adults with pyruvate kinase deficiency.. Eur J Haematol. 106(4):484-492.

Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM et al..  2018.  Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.. Blood. 131(20):2183-2192.

Weiss M, Jun MParisi, Sheth S.  2019.  Clinical and economic burden of regularly transfused adult patients with β-thalassemia in the United States: A retrospective cohort study using payer claims.. Am J Hematol. 94(5):E129-E132.

Al-Samkari H, van Beers EJ, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kuo KHM, Kollmar N et al..  2020.  Characterization of the severe phenotype of pyruvate kinase deficiency.. Am J Hematol.

Fassel H, Sheth S.  2020.  Bone Marrow Failure in Children: Approach to Diagnosis and Treatment.. Indian J Pediatr. 87(2):141-149.